Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2026, Vol. 20 ›› Issue (06): 415-423. doi: 10.3877/cma.j.issn.1674-0785.2026.06.002

• Clinical Research • Previous Articles    

Application of the gastroesophageal reflux disease questionnaire in patients with gastroesophageal reflux disease at high altitude

Yuan Lu1, Chao Jiang2,†(), Xiaofeng Li1, Shuaitong Yang1   

  1. 1 The Third Department of General Surgery, The Affiliated Hospital of Qinghai University, Xining 810000, China
    2 The Second Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qinghai University, Xining 810000, China
  • Received:2026-05-15 Online:2026-06-30 Published:2026-11-16
  • Contact: Chao Jiang

Abstract:

Objective

To evaluate the diagnostic efficacy of the Gastroesophageal Reflux Disease Questionnaire (GerdQ) in patients with gastroesophageal reflux disease (GERD) at high altitude, and to identify factors influencing the therapeutic effect of proton pump inhibitors (PPIs).

Methods

A retrospective study was conducted on 560 patients with suspected GERD at the Affiliated Hospital of Qinghai University from July 2024 to July 2025. Diagnosis was established primarily by upper gastrointestinal endoscopy, with a PPI test (esomeprazole 40 mg/d for 14 days) reserved for endoscopy-negative cases. Patients were classified into a GERD group (n=469) and a non-GERD group (n=91) based on diagnostic findings. All patients completed the GerdQ before and after treatment. ROC curve analysis was performed to evaluate diagnostic performance. GERD patients were further divided into a response group (n=312) and a non-response group (n=157) based on the post-treatment 4-item GerdQ score. Multivariate Logistic regression was used to identify independent risk factors for treatment failure, and a nomogram prediction model was constructed.

Results

The pretreatment GerdQ score was significantly higher in the GERD group than in the non-GERD group (9.57±2.26 vs 5.64±2.25; mean difference 3.93, 95%CI: 3.42~4.44; P<0.001). The optimal cutoff value for GerdQ in diagnosing GERD was ≥ 8, yielding an AUC of 0.893 (95%CI: 0.862~0.924), sensitivity of 89.1% (95%CI: 85.8%~91.9%), and specificity of 76.9% (95%CI: 66.9%~85.0%). After PPI treatment, 157 patients (33.5%) showed poor response. Multivariate Logistic regression analysis identified BMI≥25 kg/m2 (OR=2.03, 95%CI: 1.33~3.09), smoking/alcohol consumption (OR=3.05, 95%CI: 1.99~4.68), baseline GerdQ score ≥10 (OR=2.54, 95%CI: 1.67~3.86), and high-risk occupations (herdsmen, drivers; OR=2.05, 95%CI: 1.12~3.76) as independent risk factors for PPI treatment failure (all P<0.05). The nomogram model incorporating these factors demonstrated good predictive performance (C-index=0.730, 95%CI: 0.681~0.779). Internal validation using bootstrap with 1000 resamples yielded a C-index of 0.724, a calibration slope of 0.972, and a mean absolute error of 0.074.

Conclusion

The GerdQ demonstrates excellent diagnostic efficacy for GERD in high-altitude populations (AUC=0.893) with high sensitivity, supporting its use in early screening and primary care. PPI response is influenced by multiple factors, with BMI, lifestyle habits, symptom severity, and occupation type serving as independent predictors. The nomogram model (C-index=0.730) with satisfactory discrimination and calibration facilitates early identification of patients at high risk for PPI treatment failure, enabling individualized precise treatment.

Key words: Gastroesophageal reflux disease, High-altitude area, GerdQ, Proton pump inhibitors, Diagnostic efficacy, Nomogram

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd